Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Profit After Tax: 2019-2025

Historic Profit After Tax for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to -$37.9 million.

  • Benitec Biopharma's Profit After Tax fell 84.63% to -$8.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$38.0 million, marking a year-over-year decrease of 73.75%. This contributed to the annual value of -$37.9 million for FY2025, which is 73.93% down from last year.
  • Per Benitec Biopharma's latest filing, its Profit After Tax stood at -$37.9 million for FY2025, which was down 73.93% from -$21.8 million recorded in FY2024.
  • Over the past 5 years, Benitec Biopharma's Profit After Tax peaked at -$13.9 million during FY2021, and registered a low of -$37.9 million during FY2025.
  • Over the past 3 years, Benitec Biopharma's median Profit After Tax value was -$21.8 million (recorded in 2024), while the average stood at -$26.4 million.
  • Data for Benitec Biopharma's Profit After Tax shows a maximum YoY tumbled of 73.93% (in 2025) over the last 5 years.
  • Benitec Biopharma's Profit After Tax (Yearly) stood at -$13.9 million in 2021, then slumped by 30.99% to -$18.2 million in 2022, then fell by 7.64% to -$19.6 million in 2023, then declined by 11.22% to -$21.8 million in 2024, then slumped by 73.93% to -$37.9 million in 2025.